All data are based on the daily closing price as of April 28, 2025
k

Kaneka

4118.TSE
24.40 USD
0.01
+0.04%

Overview

Last close
24.40 usd
Market cap
1.54B usd
52 week high
28.08 usd
52 week low
21.82 usd
Target price
28.93 usd

Valuation

P/E
8.1234
Forward P/E
N/A
Price/Sales
0.2765
Price/Book Value
0.4739
Enterprise Value
2.65B usd
EV/Revenue
0.4752
EV/EBITDA
8.2346

Key financials

Revenue TTM
5.58B usd
Gross Profit TTM
1.55B usd
EBITDA TTM
562.52M usd
Earnings per Share
3 usd
Dividend
0.8 usd
Total assets
5.81B usd
Net debt
1.03B usd

About

Kaneka Corporation engages in the manufacture and sale of polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan and internationally. It provides impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, and biodegradable polymer, as well as engineering resin for injection molding, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; and organic EL lighting panels, lithium-ion battery, and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. Additionally, it provides dairy products, yogurt, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, which include coenzyme, probiotics, and dietary ingredients, as well as fertilizers. Kaneka Corporation was incorporated in 1949 and is headquartered in Tokyo, Japan.
  • Symbol
    4118.TSE
  • Exchange
    TSE
  • Isin
    JP3215800008
  • Country
    Japan
  • Sector
    Basic Materials
  • Industry
    Specialty Chemicals
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.kaneka.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top